|
|
|
| Join the 14th Injectables Summit (October 1-3, Boston) to streamline your injectable combination device. Gain technical takeaways and practical insights from over 80 industry leaders as we delve into next-generation devices and AI integration. |
|
|
|
|
By Shaun Bagai, CEO, RenovoRx Inc. | Trans-arterial micro-perfusion (TAMP) is a novel approach designed to use pressure to deliver therapeutic agents directly to tumor sites. |
|
|
|
| Transitioning From Vial To Prefilled Syringe | Article | By Natasha Van Rutten, Catalent | Understand how formulation development for a prefilled syringe affects manufacturing, driving the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. |
|
|
| Why “Off-The-Shelf” Devices Do Not Circumvent Design Controls | Article | By Jason Miller, Kymanox Corporation | Utilizing off-the-shelf (OTS) devices for drug delivery can offer significant advantages in timeline and risk mitigation. Understand the design control responsibilities of a sponsor when using OTS devices. |
|
|
| Delivering Market Success For Pharma Partners From Concept To Patient | Article | By Shari Krusniak and Patrick McLoughlin, West Pharmaceutical Services, Inc. | The development of drug delivery devices that are innovative, intuitive, patient friendly, and patient safe must address certain areas of concern that are particular to both biologic and biosimilar therapies. |
|
|
|
|
| Small Is Powerful And Sustained | Article | Nanoform | Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance. |
|
|
|
|
|
|
.png){kind=logo}
